Monte Rosa Therapeutics said preclinical data at ACR26 showed MRT-8102 inhibited NLRP3 inflammasome activation in human experimental systems and showed anti-inf

BWB News TV • 2026-11-09 12:36 UTC • By Billy Odell Tucker-Robinson

Monte Rosa Therapeutics said preclinical data at ACR26 showed MRT-8102 inhibited NLRP3 inflammasome activation in human experimental systems and showed anti-inflammatory activity in a rabbit gout model, supporting its inflammation pipeline.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly